Mergers & Acquisitions Mergers & Acquisitions

AbbVie-Allergan deal gets US FTC sign-off in contentious commission vote

By Jenna Ebersole
  • 06 May 2020 17:19
  • 06 May 2020 17:19
AbbVie and Allergan's deal won US Federal Trade Commission clearance yesterday in a vote split along familiar partisan lines, with Democratic Commissioner Rohit Chopra blasting the settlement and Republicans accusing him of not letting the facts “get in the way of a good story.”

Commissioners voted 3-2 to allow the $63 billion

To view the latest version of this document and thousands of others like it, sign-in to MLex or register for a free trial.

Discover MLex

Stay on top of global regulatory developments


Latest News